Detraxi Overview
- Founded
-
2001
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
2
Detraxi General Information
Description
Developer of artificial blood and a biotechnology system designed to preserve and regenerate human organs. The company is developing proprietary biotech solutions that will address both the global blood shortage and organ donation crisis.
Contact Information
Website
www.detraxi.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Primary Office
- 1312 Commerce Lane
- Suite 16B
- Jupiter, FL 33458
- United States
+1 (561) 000-0000
Detraxi Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Detraxi Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Abhishek Choudhary | Finance Director | ||
| Rachel Selesky | Chief Marketing and Brand Development Officer | ||
| Joseph Fischer | Chief Technology Officer |
Detraxi Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Detraxi Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|